Medication use in Poland for children and adolescents with neurodevelopmental disorders: before, during and after the COVID-19 pandemic - a retrospective pharmacoepidemiological study using national reimbursement data
The COVID-19 pandemic induced broad but temporary increases in pediatric psychotropic drug dispensing, except for ADHD pharmacotherapies, which demonstrated a persistent upward trend. These findings suggest lasting shifts in diagnostic and therapeutic practices and underscore the need for continued monitoring of stimulant use and prescribing appropriateness in pediatric neurodevelopmental care.
Authors
- Malwina Hołownia-Voloskova (ORCID: https://orcid.org/0000-0002-2437-298X)
- Andrzej Silczuk (ORCID: https://orcid.org/0000-0002-7048-8094)
- Katarzyna Maria Bliźniewska-Kowalska (ORCID: https://orcid.org/0000-0002-9779-7057)
- Anna Mosiołek (ORCID: https://orcid.org/0000-0001-6999-2309)
- O. Roubinek (ORCID: https://orcid.org/0000-0002-6492-7118)
- Marcin Czech (ORCID: https://orcid.org/0000-0001-7292-1712)
- Krzysztof Marcin Zakrzewski
Institutions
- SGH Warsaw School of Economics (PL)
- Medical University of Warsaw (PL)
- Medical University of Lodz (PL)
- Łukasiewicz Research Network (PL)
- The Maria Grzegorzewska University (PL)
Publication Details
- Journal
- Frontiers in Pharmacology
- Published
- 2026-01-07
- DOI
- https://doi.org/10.3389/fphar.2025.1728388
- Primary Topic
- Pharmaceutical studies and practices
- Type
- article
- Field-Weighted Citation Impact
- 0.00